• +1-646-491-9876
    • +91-20-67278686

    Search

    Typhoid Fever - Pipeline Review, H1 2017

    Typhoid Fever - Pipeline Review, H1 2017

    • Report Code ID: RW0001689390
    • Category Healthcare
    • No. of Pages 41
    • Publication Month Feb-17
    • Publisher Name Global Markets Direct
    Report Summary

    Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Typhoid Fever - Pipeline Review, H1 2017, provides an overview of the Typhoid Fever (Infectious Disease) pipeline landscape.

    Typhoid fever is an infection that causes diarrhea and a rash. It is most commonly due to a type of bacterium called Salmonella typhi (S. typhi). Symptoms include abdominal tenderness, agitation, chills, delirium, hallucinations, severe fatigue and weakness. Treatment includes antibiotics and supportive therapy.

    Report Highlights

    Publisher's Pharmaceutical and Healthcare latest pipeline guide Typhoid Fever - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Typhoid Fever (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

    The Typhoid Fever (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Typhoid Fever and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 2, 1, 1, 4, 1 and 1 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules, respectively.

    Typhoid Fever (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

    Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

    Report Scope

    - The pipeline guide provides a snapshot of the global therapeutic landscape of Typhoid Fever (Infectious Disease).
    - The pipeline guide reviews pipeline therapeutics for Typhoid Fever (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
    - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
    - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
    - The pipeline guide reviews key companies involved in Typhoid Fever (Infectious Disease) therapeutics and enlists all their major and minor projects.
    - The pipeline guide evaluates Typhoid Fever (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
    - The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
    - The pipeline guide reviews latest news related to pipeline therapeutics for Typhoid Fever (Infectious Disease)

    Reasons to buy

    - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
    - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
    - Find and recognize significant and varied types of therapeutics under development for Typhoid Fever (Infectious Disease).
    - Classify potential new clients or partners in the target demographic.
    - Develop tactical initiatives by understanding the focus areas of leading companies.
    - Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
    - Formulate corrective measures for pipeline projects by understanding Typhoid Fever (Infectious Disease) pipeline depth and focus of Indication therapeutics.
    - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
    - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
    Table of Contents
    List of Tables
    List of Figures
    Introduction
    Publisher Report Coverage
    Typhoid Fever - Overview
    Typhoid Fever - Therapeutics Development
    Pipeline Overview
    Pipeline by Companies
    Pipeline by Universities/Institutes
    Products under Development by Companies
    Products under Development by Universities/Institutes
    Typhoid Fever - Therapeutics Assessment
    Assessment by Target
    Assessment by Route of Administration
    Assessment by Molecule Type
    Typhoid Fever - Companies Involved in Therapeutics Development
    GlaxoSmithKline Plc
    Indian Immunologicals Ltd
    Nanotherapeutics Inc
    Prokarium Ltd
    Protein Potential LLC
    Sanofi Pasteur SA
    Shantha Biotechnics Ltd
    SK Chemicals Co Ltd
    Zydus Cadila Healthcare Ltd
    Typhoid Fever - Drug Profiles
    (paratyphoid (bivalent) + typhoid) vaccine - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    (paratyphoid + typhoid) vaccine - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    (shigella + typhoid) vaccine - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    (Streptococcal pneumonia + typhoid) vaccine - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Typhella - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    typhoid vaccine - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    typhoid vaccine - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    typhoid vaccine - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    typhoid vaccine - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    typhoid Vi polysaccharide [strain S typhi Ty2] vaccine - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    ViCRM-197 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Typhoid Fever - Dormant Projects
    Typhoid Fever - Discontinued Products
    Typhoid Fever - Product Development Milestones
    Featured News & Press Releases
    Oct 05, 2012: Sanofi Pasteur Voluntarily Recalls Few Batches Of Typhoid Fever Vaccine
    Jun 23, 2011: Sanofi Pasteur’s Typhim Vi Receives Prequalification From World Health Organization
    Jun 05, 2008: Emergent BioSolutions Initiates U.S. Phase II Trial of Oral Typhoid Vaccine Candidate
    Jan 08, 2008: Emergent BioSolutions Announces Final Phase II Clinical Study Results for Typhoid Vaccine
    Nov 21, 2005: Emergent Biosolutions Starts Clinical Study Of Single-Dose Oral Typhoid Vaccine
    Aug 30, 2005: Emergent Biosolutions' Typhoid Vaccine Achieves Positive Results In Phase II Clinical Study
    Nov 29, 1994: Food And Drug Administration Grants License For A New Typhoid Fever Vaccine
    Appendix
    Methodology
    Coverage
    Secondary Research
    Primary Research
    Expert Panel Validation
    Contact Us
    Disclaimer

    List of Tables

    Number of Products under Development for Typhoid Fever, H1 2017
    Number of Products under Development by Companies, H1 2017
    Number of Products under Development by Universities/Institutes, H1 2017
    Products under Development by Companies, H1 2017
    Products under Development by Universities/Institutes, H1 2017
    Number of Products by Stage and Target, H1 2017
    Number of Products by Stage and Route of Administration, H1 2017
    Number of Products by Stage and Molecule Type, H1 2017
    Typhoid Fever - Pipeline by GlaxoSmithKline Plc, H1 2017
    Typhoid Fever - Pipeline by Indian Immunologicals Ltd, H1 2017
    Typhoid Fever - Pipeline by Nanotherapeutics Inc, H1 2017
    Typhoid Fever - Pipeline by Prokarium Ltd, H1 2017
    Typhoid Fever - Pipeline by Protein Potential LLC, H1 2017
    Typhoid Fever - Pipeline by Sanofi Pasteur SA, H1 2017
    Typhoid Fever - Pipeline by Shantha Biotechnics Ltd, H1 2017
    Typhoid Fever - Pipeline by SK Chemicals Co Ltd, H1 2017
    Typhoid Fever - Pipeline by Zydus Cadila Healthcare Ltd, H1 2017
    Typhoid Fever - Dormant Projects, H1 2017
    Typhoid Fever - Discontinued Products, H1 2017

    List of Figures

    Number of Products under Development for Typhoid Fever, H1 2017
    Number of Products under Development by Companies, H1 2017
    Number of Products by Targets, H1 2017
    Number of Products by Stage and Targets, H1 2017
    Number of Products by Routes of Administration, H1 2017
    Number of Products by Stage and Routes of Administration, H1 2017
    Number of Products by Molecule Types, H1 2017
    Number of Products by Stage and Molecule Types, H1 2017
    GlaxoSmithKline Plc
    Indian Immunologicals Ltd
    Nanotherapeutics Inc
    Prokarium Ltd
    Protein Potential LLC
    Sanofi Pasteur SA
    Shantha Biotechnics Ltd
    SK Chemicals Co Ltd
    Zydus Cadila Healthcare Ltd

    Request for Sample

    Report Url http://www.reportsweb.com//typhoid-fever-pipeline-review-h1-2017&type=sample
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire before Buying

    Report Url http://www.reportsweb.com//typhoid-fever-pipeline-review-h1-2017&type=buying
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire for Discount

    Report Url http://www.reportsweb.com//typhoid-fever-pipeline-review-h1-2017&type=discount
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments